GGrantIndex
← Search

HUMAN TUMOR NECROSIS FACTOR RECEPTOR PROTEIN IN CHF

$0M01FY2000RRNIH

University Of North Carolina Chapel Hill, Chapel Hill NC

Investigators

Linked publications & trials

Abstract

This study will evaluate the effects of recombinant human tumor necrosis factor receptor fusion protein (etanercept) in patients with chronic heart failure.

View original record on NIH RePORTER →